Aug 4, 2020 | Cancer Center News
CHAMPAIGN, Ill. — As the COVID-19 pandemic continues to spread, scientists and health care providers are seeking ways to keep the coronavirus from infecting tissues once they’re exposed. A new study suggests luring the virus with a decoy – an engineered,...
Jul 29, 2020 | Cancer Center News
CCIL members and campus researchers are encouraged to attend the Tumor Engineering and Phenotyping (TEP) lab’s online webinar on Aug. 5 at 11 a.m. to learn more about the NanoString nCounter SPRINT Profiler, a shared resource for campus users available starting in...
Jun 30, 2020 | Cancer Center News
CHAMPAIGN, Ill. — A method known as CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia. It modifies a patient’s own T-cells by adding a piece of an antibody that recognizes unique features on the surface of cancer...
Jun 26, 2020 | Cancer Center News
Researchers at the Beckman Institute for Advanced Science and Technology have developed a new method to improve the detection ability of nanoscale chemical imaging using atomic force microscopy. These improvements reduce the noise that is associated with the...
Mar 5, 2020 | Cancer Center News
Wawrzyniec Dobrucki, professor of bioengineering, and Auinash Kalsotra, professor of biochemistry, have published their research on myotonic dystrophy, which generates lethal heart dysfunctions. The researchers and their team genetically engineered mice to express the...
Feb 6, 2020 | Cancer Center News
Two grants will fund interdisciplinary research at the Beckman Institute for Advanced Science and Technology, including a look at how neurons and muscle cells communicate with each other and also to develop a drug delivery system for treatment of Alzheimer’s disease....
Dec 9, 2019 | Cancer Center News
Stephen Boppart, David Kranz Stephen Boppart, CCIL Program Leader, and David Kranz, CCIL Deputy Director, are two of 168 academics across the world elected as 2019 National Academy of Inventors Fellows, who are recognized for their outstanding inventions that make a...
Nov 4, 2019 | Cancer Center News
Kai Zhang CCIL member Kai Zhang , professor of biochemistry, developed a novel optogenetic technique, called GLIMPSe, to use light to control and stabilize the lifetime of intracellular proteins. Zhang stated that this method is a nontoxic and more efficient way to...
